Miyazawa et al. found that Cisplatin inhibited the iron regulatory protein 2, caused intracellular iron deficiency and thus leaded to dysregulated iron metabolism, which could finally result in cancer cell death (Miyazawa et al., 2019). Here, IREB2 is linked to cancer.